Connacht Asset Management LP Guardant Health, Inc. Transaction History

Connacht Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $124,223 - $291,905	4,883 Added 68.15%	12,048 $327,000
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $20,694 - $28,914	474 Added 7.08%	7,165 $386,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $192,834 - $517,548	6,691 New	6,691 $270,000
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $1.65 Million - $2.32 Million	-12,976 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $1.3 Million - $1.76 Million	12,976 New	12,976 $1.67 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.